Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

Sun Yat-sen University

Status: Enrolling

Conditions: Primary Electrical Disease; Multi-modality Echocardiography

Treatments: Diagnostic Test: Echocardiography

Study type: Observational

Funder types: Other

Identifiers

NCT06172842

SYSKY-2023-1069-01

Details and patient eligibility

About

From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.

Enrollment: 30 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• primary electrical disease

Exclusion criteria

• Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease

Trial design

30 participants in 2 patient groups

primary electrical disease

Treatment:

Diagnostic Test: Echocardiography

control

Treatment:

Diagnostic Test: Echocardiography